These compounds may interact with:
Cytochrome P450 2D6
Potentially involved in: carcinoma; autoimmune hepatitis; cancer; schizophrenia; pain agnosia; neuroleptic malignant syndrome; parkinson's disease; major depressive disorder; amelogenesis imperfecta; liver disease; schizoaffective disorder; hepatitis c; attention deficit hyperactivity disorder; obsessive-compulsive disorder; delusional disorder; alzheimer's disease; hepatitis d; constipation; multiple chemical sensitivity; malaria
Disease data sourced from Pharos.